FDA approve SurgiClear (Covalon Technologies) for Wound Healing

The FDA has cleared SurgiClear (antimicrobial dressing), from Covalon Technologies, to cover and protect Wound sites and wound closure devices, as well as secure other primary dressings to a patient's skin. SurgiClear is the first clear antimicrobial silicone surgical dressing that combines silver and chlorhexidine to provide broad spectrum antimicrobial activity for 7 days. SurgiClear is the only antimicrobial surgical dressing in the market to meet current FDA standards for the antimicrobial claim �greater than 4 log reduction�. The soft skin silicone adhesive provides maximum patient comfort, will not macerate or damage the skin, and has the potential to reduce keloid scarring. It also allows clinicians to monitor wounds through its clear waterproof film so patients can resume normal activity without fear of contamination or damage to a wound site.